NEW YORK, April 26, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
http://www.reportlinker.com/p0484898/Epidemiology-Psoriasis.html
By 2019, the seven major markets will count 15 million psoriasis cases; around half of which will be living in the US. With the exception of Japan, the psoriasis population is expected to increase in all markets. Gain insight to market potential, including a robust 10-year epidemiology forecast of prevalent psoriasis cases. Understand the key epidemiologic risk factors associated with psoriasis disease. Of the seven major markets (the US, Japan, France, Germany, Italy, Spain, and the UK), psoriasis prevalence is expected to increase the most in the US, less in Europe, and decline slightly in Japan over the next decade Psoriasis is a life-long disease with low mortality and high morbidity, which can severely affect a patient's quality of life. What are the most robust epidemiologic studies for psoriasis prevalence data? How will the patient population change over the next decade in the US, Japan, and five major EU markets (France, Germany, Italy, Spain, and the UK)?How do changes in population structure and risk factors affect the trend in prevalent psoriasis cases?
Executive Summary
Key findings
OVERVIEW
Catalyst
Summary
DISEASE DEFINITION AND DIAGNOSIS CRITERIA
Disease definition
GLOBAL VARIATION AND HISTORICAL TRENDS
Prevalence
Incidence
CO-MORBIDITIES
Psychiatric and cardiovascular diseases are the most common co-morbidities
RISK FACTORS
Genetics and demographics
Genetic predisposition
Lifestyle factors
Smoking and alcohol
Other factors
Obesity, cardiovascular disease and immunity
EPIDEMIOLOGIC FORECASTING OF PSORIASIS
Sources of epidemiologic data
Description of methods
US
Japan
European markets
France
Germany
Italy
Spain
UK
EPIDEMIOLOGIC RESULTS
Current prevalent cases and future trends
DISCUSSION
Strengths and limitations of our epidemiologic projections
BIBLIOGRAPHY
Journal papers
Websites
APPENDIX A
Report methodology
To order this report:
Check our Company Profile, SWOT and Revenue Analysis!
Nicolas Bombourg
Reportlinker
Email: [email protected]
US: (805)652-2626
Intl: +1 805-652-2626
SOURCE Reportlinker
Share this article